Peter Attia· MD
So you basically, if you blindly develop drugs against cancer cells- to find out what's poisonous to them. And then you filter those in mice to see what kills the mice at equal concentrations versus what doesn't quite kill them. And you call that your possible therapeutic. What will you get out of that? This is one of my first lectures that I used to give to medical students about cancer therapeutics as I was trying to outline a path forward, is that basically what you get out of that is all these agents that tangle the DNA and some microtubules stabilizing and destabilizing drugs.